572 consecutive patients with heart failure referred to the National Cardiothoracic Centre, Accra, Ghana, over a 4-year period were evaluated for the aetiology of heart failure using two-dimensional Doppler echocardiography with colour flow. The mean age of the subjects with heart failure was 42.3 ± 0.9 years. The male to female ratio was 1.2:1.0. Combined heart failure was seen in 50.5% of subjects. Peak incidence of heart failure occurred in the 5th decade. The main causes of heart failure were hypertension (21.3%; n = 122), rheumatic heart disease (20.1%; n = 115) and cardiomyopathy (16.8%; n = 96). Congenital heart disease and coronary artery disease accounted for 9.8 and 10% of cases, respectively. The commonest rheumatic valvular lesion was mitral regurgitation (78%). Dilated cardiomyopathy was the commonest form of idiopathic cardiomyopathy (67.7%; n = 65). Endomyocardial fibrosis and hypertrophic cardiomyopathy accounted for 22.9% (n = 22) and 9.4% (n = 9), respectively, of cardiomyopathies.

Keywords:
Heart failure, aetiology, Hypertension, Echocardiography, Heart disease, rheumatic, Heart disease, congenital, Cardiomyopathy, Endomyocardial fibrosis, Africa
1.
Committee on Research, Development and Institutional Strengthening for Control of Cardiovascular Diseases in Developing Countries: The future burden of cardiovascular diseases in developing countries; in Howson CP, Srinath Reddy K, Ryan TJ, Bale JR (eds): Control of Cardiovascular Diseases in Developing countries. Research, Development, and Institutional Strengthening. Board on International Health. Institute of Medicine, Washington, National Academy Press, 1998.
2.
Mensah GG, Barkey NL, Coopers RS: Spectrum of hypertensive target organ damage in Africa: A review of published studies. J Hum Hypertens 1994;8:799–808.
3.
Muna WF: Cardiovascular disorders in Africa. World Health Stat Q 1993;46:125–133.
4.
Kpodonu J, Pobee JOM, Larbi EB, Chkwemeka A, Chuwa M, Johnson A: Five years of Cardioac Register with particular reference to cardiomyopathies. Ghana Med J 1980;19:134–139.
5.
Lore W: Epidemiology of cardiovascular diseases in Africa with special reference to Kenya: An overview. East Afr Med J 1993;70:357–361.
6.
Hodes RM: Pattern of heart disease in Ethiopia as seen in a cardiology referral clinic. Cardiology 1988;75:458–464.
7.
Abraham G: Pattern of cardiovascular disease among adult hospitalized Ethiopians. Ethiop Med J 1982;20:63–68.
8.
Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269–1276.
9.
Pobee JOM: A review of the causes of death in adult medical wards of Korle Bu Teaching Hospital, Accra, Ghana. Afr Med Sci 1976;5:79–85.
10.
Falase AO, Ayeni O, Sekoni GA, Odia OJ: Heart failure in Nigerian hypertensives. Afr J Med Sci 1983;12:7–15.
11.
Carlisle R, Ogunlesi TO: Prospective study of adult cases presenting at the Cardiac Unit, University College Hospital, Ibadan, 1968 and 1969. Afr J Med Sci 1972;3:13–25.
12.
Strang G: Echocardiography in the developing world; in Wilde P (ed): Cardiac Ultrasound. Edinburgh, Churchill Livingstone, 1993, pp 289–303.
13.
Strang JIG: Echoes from the Third World – Two dimensional echocardiography in a developing country. S Afr Med J 1990;77:85–91.
14.
Ikeme AC, Blankson J, Larbi E, Pobee JOM, Pole D: Obscure cardiomegaly from a cardiovascular survey; in Akinkugbe OO (ed): Cardiovascular Disease in Africa. Basel, Ciba-Geigy, 1976, pp 42–47.
15.
Ikeme AC: Idiopathic cardiomegaly in Africa; in Akinkugbe OO (ed): Cardiovascular Disease in Africa. Basel, Ciba Geigy, 1976, pp 15–23.
16.
Feigenbaum H: Echocardiography, ed 4. New York, Lea & Febiger, 1986.
17.
Houston AB, Simpson IA: Cardiac Doppler Ultrasound – A Clinical Perspective. Bristol, Wright, 1988.
18.
Sutton J, Oldershaw P: Textbook of Adult and Pediatric Echocardiography and Doppler. Oxford, Blackwell Scientific, 1989.
19.
Primary Prevention of Essential Hypertension: Report of a WHO Scientific Group. Geneva, World Health Organization, 1983, WHO Technical Report Series No 686.
20.
The fifth report of the Joint National Committee on Detection. Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1993;153:154–183.
21.
Criteria Committee, New York Heart Association: Diseases of Heart and Blood Vessels. Nomenclature and Criteria for Diagnosis, ed 6. Boston, Little, Brown, 1964, p 114.
22.
Clinical Practice Guidelines for the treatment of diabetes mellitus. Expert Committee of the Canadian Diabetes Advisory Board. Can Med J 1992;147:697–712.
23.
Feinstein AR: Clinical Judgement. Baltimore, Williams & Wilkins, 1967.
24.
McKee PA, Castelli WP, McNamara PM, Kannel WB: The natural history of congestive heart failure, the Framingham Study. N Engl J Med 1971;285:1441.
25.
Maranz PR, Tobin JN, Wassertheil-Smoller S, Steingart RM, Wexler JP, Budner N, Lense L, Wachspress J: The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation 1988;77:607–612.
26.
Akinkugbe OO, Falase AO: Clinical Medicine in the Tropics Series. Cardiovascular Disease. Oxford, Blackwell Scientific, 1987, pp 65–71.
27.
Makene WS: Hypertension in Dar es Salaam; in Kamunvi F, Ojiambo HP, Bajusz E (eds): Myocardiology in Africa – Proceedings of the International Symposium on Preventive Cardiology and Cardiac Metabolism. Nairobi, East Afr Lt Bureau, 1974, vol 1, pp 218–223.
28.
Markowitz M: Observations on the epidemiology and preventability of rheumatic fever in developing countries. Clin Ther 1981;4:240–251.
29.
Markowitz M: Rheumatic fever in the eighties. Pediatr Clin North Am 1986;33:1141–1150.
30.
Markowitz M: The decline of rheumatic fever: Role of medical intervention. J Pediatr 1985;106:545–550.
31.
Gordis L: The virtual disappearance of rheumatic fever in the Unites States: Lessons in the rise and fall of disease. T. Duckett Jones memorial lecture. Circulation 1985;72:1155–1162.
32.
Anabwani GM, Book W, Bonhoeffer P: Echocardiographic findings in Eldoret: Retrospective study. East Afr Med J 1996;73:714–716.
33.
Menge I, Erasmai F, Van Reken D, Anabwani G: Paediatric morbidity and mortality at the Eldoret District Hospital, Kenya. East Afr Med J 1995;72:165–169.
34.
Parker AHT: Cardiac disorders in Nairobi. East Afr Med J 1973;50:530–536.
35.
Spencer SS, Makene WJ: Rheumatic heart disease in Tanzania. East Afr Med J 1972;49:909–920.
36.
Padmevati S: Rheumatic fever and rheumatic heart disease in developing countries. Bull WHO 1978;56:543–550.
37.
Oli K, Tekle-Haimanot R, Forsgren L, Ekstedt J: Rheumatic Heart Disease prevalence among schoolchildren of an Ethiopian rural town. Cardiology 1992;80:152–155.
38.
Kahare AM, Amabwamo G, Mugambi M: Valvular heart disease as seen at cardiac catheterization at the Kenyatta National Hospital Nairobi. East Afr Med 1986;63:803–806.
39.
Pole D, Pobee J, Ikeme A, Larbi E, Johnson A: A computerized cardiac register: 12 months’ experience. Trop Cardiol 1976;2:135–139.
40.
Rose AG, Fraser RC, Beck W: Absence of evidence of myocarditis in endomyocardial biopsy specimens from patients with dilated (congestive) cardiomyopathy. S Afr Med 1984;66:871–874.
41.
Attah EB, Falase AO: Large flabby hearts in hypertension. Am Heart J 1977;94:189–195.
42.
Lowenthal MN: Hypertensive heart disease and cardiomyopathy in blacks. Diagnostic confusion. S Afr Med J 1979;55:547–549.
43.
Editoral (anonymous): Dilated cardiomyopathy in Africa. Lancet 1985;i:557–558.
44.
Bertrand E, Renambot J, Chauvet J, Ekra A: Aspects angiocardiographiques et phonomécanographiques de la fibrose endomyocardique constrictive; in Akinkugbe OO (ed): Cardiovascular Disease in Africa. Basel, Ciba-Geigy, 1976, pp 79–82.
45.
Parry EHO, Abrahams DG: The natural history of endomyocardial fibrosis. Q J Med 1965;34:383–408.
46.
Laing WN: Sudden, unexpected und unexplained deaths in Accra. Ghana Med J 1968;7:170–184.
47.
Laing WN: The pattern of cardiovascular and renal causes of obscure deaths in Accra, Ghana. Ghana Med J 1969;8:254–258.
48.
Acquatella H, Schiller NB: Echocardiographic recognition of Chagas’ disease and endomyocardial fibrosis. J Am Soc Echocardiogr 1988;1:60–68.
49.
el Hag AJ: Pattern of congenital heart disease in Sudanese children. East Afr Med J 1994;71:580–586.
50.
Maru M: The changing pattern of cardiovascular diseases in Ethiopia. East Afr Med J 1993;70:772–776.
51.
Dodu SRA: Clinical aspects of ischaemic heart disease (IHD) in Ghanaians. Ghana Med J 1972;11:203–214.
52.
Prevention in Childhood and Youth of Adult Cardiovascular Diseases. Time for Action, Report of WHO Expert Committee. Geneva, World Health Organization, 1990, Technical Report Series No 792.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.